Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Cost for lisinopril?

See the DrugPatentWatch profile for lisinopril

Prices for lisinopril vary a lot by country, dosage, quantity, and whether you have insurance or a discount card. Here’s a rough US ballpark to help you estimate:

- Generic lisinopril (10 mg or 20 mg) 30-day supply (30 tablets): about $4–$15 cash price with a discount card; without discounts it can be higher, but still generally inexpensive.
- 90-day supply (90 tablets): roughly $12–$40 cash price.
- With insurance: typical copays often range from $0 to around $15 per month, depending on the plan.

If you’re outside the US, prices can be quite different, but generics are usually the cheaper option.

To get a precise price for you:
- Tell me your country.
- Tell me the dosage (e.g., 5 mg, 10 mg, 20 mg) and the quantity (30-day vs 90-day).
- Do you have insurance or a discount card?

I can also help you look up current prices at local pharmacies or suggest discount programs (e.g., GoodRx) to compare costs.



Other Questions About Lisinopril :

lisinopril names Is lisinopril generic or brand name? Lisinopril generic brand? Lisinopril average total drug cost per prescription 2023? Lisinopril 20 mg price without insurance? Does lisinopril contain calcium? Lisinopril hctz maximum dosage?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The AI claim exactly matches the FDA boxed warning and related Warnings language to discontinue lisinopril/hydrochlorothiazide as soon as possible when pregnancy is detected due to fetal toxicity risk.


Category Scores

Warnings
100
Excellent

Accurate Statements

When pregnancy is detected, discontinue lisinopril and hydrochlorothiazide tablets as soon as possible due to fetal toxicity risk.
Supported by Boxed Warning: "When pregnancy is detected, discontinue lisinopril and hydrochlorothiazide tablets as soon as possible." and by Warnings: "When pregnancy is detected, discontinue lisinopril and hydrochlorothiazide tablets as soon as possible."

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The evaluated statement is an on-label, boxed-warning instruction consistent with FDA labeling.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned

Primary Issue

Suggested Improvement